883893-69-4

Basic information

• Product Name: Silane, [1,3,5-benzenetriyltris(methyleneoxy)]tris[(1,1-dimethylethyl)dimethyl-
• CAS NO: 883893-69-4
• Molecular Formula: C27H54O3Si3
• Molecular Weight: 510.98
• Mol File: 883893-69-4.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Silane, [1,3,5-benzenetriyltris(methyleneoxy)]tris[(1,1-dimethylethyl)dimethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Silane, [1,3,5-benzenetriyltris(methyleneoxy)]tris[(1,1-dimethylethyl)dimethyl-(883893-69-4)
• EPA Substance Registry System: Silane, [1,3,5-benzenetriyltris(methyleneoxy)]tris[(1,1-dimethylethyl)dimethyl-(883893-69-4)

Safety Data

• Hazardous Substances Data: 883893-69-4(Hazardous Substances Data)

Upstream product

• 4464-18-0 1,3,5-tris(hydroxymethyl)benzene 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 76782-82-6 tert-Butyldimethyl(prop-2-ynyloxy)silane 

Downstream Products

• 943326-45-2 C₂₇H₅₃NO₅Si₃ 
• 943326-46-3 C₂₇H₅₅NO₃Si₃ 
• 943326-49-6 C₄₆H₃₅N₅O₁₈ 
• 943326-48-5 C₂₅H₂₆N₂O₆ 
• 943326-47-4 C₄₃H₆₈N₂O₆Si₃ 

Relevant articles and documents

Mild ruthenium-catalyzed intermolecular alkyne cyclotrimerization

Grubbs' catalyst [(PCy3)2Cl2Ru=CHPh, 7] was shown for the first time to be an effective catalyst for the mild intermolecular cyclotrimerization of terminal alkynes (1-6). The reaction is general and the isomeric trisubstit

Iron-catalyzed regioselective cyclotrimerization of alkynes to benzenes

We report the synthesis and characterization of simple di(aminomethyl)pyridine ligated iron-pincer complexes, which catalyzed the regioselective [2+2+2] cyclotrimerization of terminal aryl and alkyl alkynes to provide the 1,2,4-trisubstituted benzene molecules. Interestingly, internal alkynes also exhibited similar cyclization and resulted in hexa-substituted benzene compounds. Increased steric bulk on pincer ligands diminished the selectivity for cycloaddition. Cyclotrimerization reactions proceeded at room temperature upon activation of catalyst by a Grignard reagent. EPR studies indicated thermally induced spin crossover effect in catalyst.

Remarkable drug-release enhancement with an elimination-based AB3 self-immolative dendritic amplifier

Self-immolative dendritic prodrugs, activated through a single catalytic reaction by a specific enzyme, could offer significant advantages in inhibition of tumor growth relative to monomeric prodrug, especially if the targeted or secreted enzyme exists at